drugset / Trial / NCT06165822
A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is a single-center, open, single-dose, self-controlled phase I clinical trial to evaluate the effects of Itraconazole Capsules/Rifampicin Capsules on pharmacokinetics of TQB3909 tablets in vivo, and the safety of TQB3909 tablets and combined with Itraconazole Capsules/Rifampicin Capsules after single oral dose.
Timeline
- Start
- 2023-12
- Primary completion
- 2024-01
- Completion
- 2024-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Itraconazole | Small molecule | 0.2 g | — |
| Subject | Rifampin | Small molecule | 0.6 g | — |
| Subject | TQB3909 | Unknown | 100 mg | Oral |